Streetbeat News

Equity Actions

SNV

Analysts have provided mixed ratings for Synovus Financial Corp (NYSE:SNV) with an updated average 12-month price target of $40.2, reflecting a 14.24% increase from the previous target. The ratings include 'Outperform', 'Strong Buy', 'In-Line', 'Equal-Weight', 'Neutral', and 'Buy'. Synovus offers a range of banking services and faces challenges such as below-average market capitalization, revenue decline, and lower net margin, ROE, and ROA compared to industry averages. However, its lower debt-to-equity ratio suggests a healthier balance between debt and equity.

Portfolio Pulse from Benzinga Insights

January 19, 2024 | 2:00 pm

SPT

Sprout Social (NASDAQ:SPT) has received mixed analyst ratings over the past three months, with 1 bullish and 4 somewhat bullish ratings. The average 12-month price target is $68.8, up from $57.75, with a high estimate of $75.00 and a low of $58.00. Analysts from Needham, Barclays, Cantor Fitzgerald, Piper Sandler, and Keybanc have adjusted their ratings and price targets, reflecting their views on the company's market performance and financial indicators. Sprout Social's financials show a revenue growth rate of 30.97% as of September 30, 2023, but it has a net margin of -26.91% and an ROE of -15.65%, indicating potential profitability and efficiency challenges.

Portfolio Pulse from Benzinga Insights

January 19, 2024 | 2:00 pm

PAYX

Paychex, Inc. has announced that its board of directors has authorized a stock repurchase program of up to $400 million of its common stock. The repurchase program is set to begin on February 1, 2024, and will expire on May 31, 2027.

Portfolio Pulse from Benzinga Newsdesk

January 19, 2024 | 1:57 pm

CISS

C3is Inc. (NASDAQ:CISS), a dry bulk and crude oil tanker transportation company, has upsized its underwritten public offering to $7 million from $6 million, offering 28 million Common Units or Pre-Funded Units at $0.25 and $0.24 respectively. The offering includes Class B-1 and B-2 Warrants with exercise prices of $0.375 and $0.425. Proceeds will go towards capital expenditures, including payment for an Aframax tanker, or for acquiring additional vessels, working capital, and other corporate purposes. The offering is set to close on January 23, 2024.

Portfolio Pulse from Benzinga Newsdesk

January 19, 2024 | 1:57 pm

NTCO

Natura &Co (NTCO) has announced its plan to delist its American Depositary Shares (ADSs) from the NYSE, while keeping its primary listing on the B3 stock exchange in São Paulo. The decision aligns with the company's strategy to simplify operations, given the low trading volume of its ADSs on the NYSE. The delisting is expected to be effective 10 days after filing a Form 25 with the SEC, with trading suspension anticipated around February 9, 2024. Natura &Co will not seek another exchange for the ADRs and will continue to uphold high disclosure standards in Brazil.

Portfolio Pulse from Benzinga Newsdesk

January 19, 2024 | 1:52 pm

STT

State Street Corporation (NYSE:STT) reported Q4 revenues of $3.04 billion, surpassing consensus estimates of $2.95 billion, with EPS of $2.04 beating estimates of $1.83. Despite a 4% Y/Y revenue decline and a 14% drop in Net interest income, the company saw flat fee revenues and a 19% increase in AUM. Expenses rose 25% Y/Y due to the FDIC special assessment. The CET1 ratio fell by 2.0% Y/Y. State Street announced a new $5 billion share repurchase authorization. Shares rose 4.29% in premarket trading.

Portfolio Pulse from Anusuya Lahiri

January 19, 2024 | 1:44 pm

EWTX

Edgewise Therapeutics has announced the pricing of its underwritten public offering of 21,818,182 shares at a price of $11.00 per share, aiming to raise $240 million.

Portfolio Pulse from Benzinga Newsdesk

January 19, 2024 | 1:41 pm

STT

State Street Corporation's stock is trading higher following the announcement of their Q4 financial results, which exceeded expectations. Additionally, the company has announced a new share repurchase program authorizing the buyback of up to $5 billion of its common shares.

Portfolio Pulse from Benzinga Newsdesk

January 19, 2024 | 1:41 pm

FSK

LAZ

SCM

Three financial stocks, FS KKR Capital Corp. (FSK), Lazard, Inc. (LAZ), and Stellus Capital Investment Corporation (SCM), are considered overbought based on their RSI values, which are above the threshold of 70. FSK's RSI is at 73.57 after a recent public offering and a price increase. LAZ's RSI is at 78.45 following an announcement of preliminary assets under management and a stock gain. SCM's RSI is at 71.32 after a downgrade by an analyst and a modest price increase.

Portfolio Pulse from Avi Kapoor

January 19, 2024 | 1:29 pm

RPRX

Royalty Pharma has announced an increase in its quarterly dividend from $0.20 to $0.21 per share.

Portfolio Pulse from Benzinga Newsdesk

January 19, 2024 | 1:23 pm